Identification and characterization of two related murine genes, Eat2a and Eat2b, encoding single SH2-domain adapters - PubMed (original) (raw)

doi: 10.1007/s00251-005-0056-3. Epub 2006 Feb 16.

Erika Erdos, Gongxian Liao, Ninghai Wang, Svend Rietdijk, Maria Simarro, Beata Scholtz, Jill Mooney, Chang Hoon Lee, Min Sun Shin, Eva Rajnavölgyi, John Schatzle, Herbert C Morse 3rd, Cox Terhorst, Arpad Lanyi

Affiliations

• PMID: 16425036
• DOI: 10.1007/s00251-005-0056-3

Identification and characterization of two related murine genes, Eat2a and Eat2b, encoding single SH2-domain adapters

Silvia Calpe et al. Immunogenetics. 2006 Feb.

Abstract

Human EAT-2 (SH2D1B) and SLAM-associated protein (SAP) (SH2D1A) are single SH2-domain adapters, which bind to specific tyrosine residues in the cytoplasmic tail of six signaling lymphocytic activation molecule (SLAM) (SLAMF1)-related receptors. Here we report that, unlike in humans, the mouse and rat Eat2 genes are duplicated with an identical genomic organization. The coding regions of the mouse Eat2a and Eat2b genes share 91% identity at the nucleotide level and 84% at the protein level; similarly, segments of introns are highly conserved. Whereas expression of mouse Eat2a mRNA was detected in multiple tissues, Eat2b was only detectable in mouse natural killer cells, CD8+ T cells, and ovaries, suggesting a very restricted tissue expression of the latter. Both the EAT-2A and EAT-2B coimmunoprecipitated with mouse SLAM in transfected cells and augmented tyrosine phosphorylation of the cytoplasmic tail of SLAM. Both EAT-2A and EAT-2B bind to the Src-like kinases Fyn, Hck, Lyn, Lck, and Fgr, as determined by a yeast two-hybrid assay. However, unlike SAP, the EAT-2 proteins bind to their kinase domains and not to the SH3 domain of these kinases. Taken together, the data suggest that both EAT-2A and EAT-2B are adapters that recruit Src kinases to SLAM family receptors using a mechanism that is distinct from that of SAP.

PubMed Disclaimer

Similar articles

• Structural basis for the interaction of the free SH2 domain EAT-2 with SLAM receptors in hematopoietic cells.
  Morra M, Lu J, Poy F, Martin M, Sayos J, Calpe S, Gullo C, Howie D, Rietdijk S, Thompson A, Coyle AJ, Denny C, Yaffe MB, Engel P, Eck MJ, Terhorst C. Morra M, et al. EMBO J. 2001 Nov 1;20(21):5840-52. doi: 10.1093/emboj/20.21.5840. EMBO J. 2001. PMID: 11689425 Free PMC article.
• SAP couples Fyn to SLAM immune receptors.
  Chan B, Lanyi A, Song HK, Griesbach J, Simarro-Grande M, Poy F, Howie D, Sumegi J, Terhorst C, Eck MJ. Chan B, et al. Nat Cell Biol. 2003 Feb;5(2):155-60. doi: 10.1038/ncb920. Nat Cell Biol. 2003. PMID: 12545174
• Association between SAP and FynT: Inducible SH3 domain-mediated interaction controlled by engagement of the SLAM receptor.
  Chen R, Latour S, Shi X, Veillette A. Chen R, et al. Mol Cell Biol. 2006 Aug;26(15):5559-68. doi: 10.1128/MCB.00357-06. Mol Cell Biol. 2006. PMID: 16847311 Free PMC article.
• The SAP and SLAM families in immune responses and X-linked lymphoproliferative disease.
  Engel P, Eck MJ, Terhorst C. Engel P, et al. Nat Rev Immunol. 2003 Oct;3(10):813-21. doi: 10.1038/nri1202. Nat Rev Immunol. 2003. PMID: 14523387 Review.
• NK cell regulation by SLAM family receptors and SAP-related adapters.
  Veillette A. Veillette A. Immunol Rev. 2006 Dec;214:22-34. doi: 10.1111/j.1600-065X.2006.00453.x. Immunol Rev. 2006. PMID: 17100873 Review.

Cited by

• Characterization of Ly108-H1 Signaling Reveals Ly108-3 Expression and Additional Strain-Specific Differences in Lupus Prone Mice.
  Rietdijk S, Keszei M, Castro W, Terhorst C, Abadía-Molina AC. Rietdijk S, et al. Int J Mol Sci. 2023 Mar 6;24(5):5024. doi: 10.3390/ijms24055024. Int J Mol Sci. 2023. PMID: 36902453 Free PMC article.
• SLAMF6 clustering is required to augment T cell activation.
  Dragovich MA, Adam K, Strazza M, Tocheva AS, Peled M, Mor A. Dragovich MA, et al. PLoS One. 2019 Jun 14;14(6):e0218109. doi: 10.1371/journal.pone.0218109. eCollection 2019. PLoS One. 2019. PMID: 31199820 Free PMC article.
• The SLAM family receptors: Potential therapeutic targets for inflammatory and autoimmune diseases.
  Dragovich MA, Mor A. Dragovich MA, et al. Autoimmun Rev. 2018 Jul;17(7):674-682. doi: 10.1016/j.autrev.2018.01.018. Epub 2018 May 3. Autoimmun Rev. 2018. PMID: 29729453 Free PMC article. Review.
• Elotuzumab for the Treatment of Relapsed or Refractory Multiple Myeloma, with Special Reference to its Modes of Action and SLAMF7 Signaling.
  Taniwaki M, Yoshida M, Matsumoto Y, Shimura K, Kuroda J, Kaneko H. Taniwaki M, et al. Mediterr J Hematol Infect Dis. 2018 Feb 15;10(1):e2018014. doi: 10.4084/MJHID.2018.014. eCollection 2018. Mediterr J Hematol Infect Dis. 2018. PMID: 29531651 Free PMC article. Review.
• Responses to Microbial Challenges by SLAMF Receptors.
  van Driel BJ, Liao G, Engel P, Terhorst C. van Driel BJ, et al. Front Immunol. 2016 Jan 20;7:4. doi: 10.3389/fimmu.2016.00004. eCollection 2016. Front Immunol. 2016. PMID: 26834746 Free PMC article. Review.

References

1. 1. Nature. 1997 Feb 13;385(6617):602-9 - PubMed
2. 1. Curr Opin Immunol. 2004 Jun;16(3):304-13 - PubMed
3. 1. Int Immunol. 2004 May;16(5):727-36 - PubMed
4. 1. Blood. 2001 Jun 15;97(12 ):3867-74 - PubMed
5. 1. J Exp Med. 2004 May 3;199(9):1245-54 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Springer

• Molecular Biology Databases

  • BioCyc
  • Gene Ontology
  • GlyGen glycoinformatics resource
  • Mouse Genome Informatics (MGI)

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal